parkinson's disease: what’s to come in 2022?
Published 2 years ago • 4.4K plays • Length 3:20Download video MP4
Download video MP3
Similar videos
-
4:55
parkinson's disease modification through c-abl inhibition
-
1:50
the role of inflammation in parkinson's disease
-
2:59
manage-pd: a tool to evaluate symptom control in parkinson’s disease
-
3:56
ikt-148009 as a potential disease-modifying therapy in parkinson's disease
-
3:11
research advancements in the pathogenesis of parkinson’s disease
-
4:53
advances in the genetics of parkinson’s disease
-
1:49
updated guideline on the treatment of parkinson's disease
-
33:52
cns pharmacology | parkinson's disease & treatment explained!
-
2:22
recent developments in parkinson's disease
-
4:47
update on disease-modifying therapies in parkinson’s disease
-
1:09
prodromal parkinson's disease: identification & ethical issues
-
1:37
the role of neuroinflammatory responses in parkinson’s disease
-
5:15
new mds task force on early-onset parkinson’s disease
-
3:41
research in parkinson’s disease: lysosomal dysfunction, immune response and antibodies
-
1:39
current guidelines for prescribing exercise to patients with parkinson’s disease
-
3:45
mri biomarkers of freezing of gait development in parkinson’s disease
-
1:39
quality of life in patients with late-stage parkinson’s disease
-
1:24
pasadena trial: prasinezumab in early parkinson's disease
-
0:56
barriers to effective symptom management in parkinson’s disease